Annual report [Section 13 and 15(d), not S-K Item 405]

Royalty and Commercial Payment Purchase Agreements - Summary of Royalty Receivable Activities (Details)

v3.26.1
Royalty and Commercial Payment Purchase Agreements - Summary of Royalty Receivable Activities (Details) - USD ($)
$ in Thousands
 1 Months Ended 12 Months Ended
Oct. 01, 2024
Apr. 01, 2024
Mar. 31, 2023
Oct. 31, 2021
Dec. 31, 2025
Dec. 31, 2024
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method            
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method         $ 56,349 $ 72,167
Acquisition of Royalty and Commercial Payment Receivables, Cost Recovery Method         4,395 45,000
Receipt of Royalty and Commercial Payments, Cost Recovery Method         (1,982) (18,938)
Recognition of Contingent Consideration, Cost Recovery Method           4,000
Credit Losses on Purchased Receivables, Cost Recovery Method           (30,904)
Reclassification of Royalty and Commercial Payment Receivables from the Cost Recovery to the EIR Method, Cost Recovery Method         (2,874) (14,976)
Balance at End of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method         55,888 56,349
Royalty and Commercial Payment Receivable Activities Under the EIR Method            
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, EIR Method         19,733  
Reclassification of Royalty and Commercial Payment Receivables from the Cost Recovery to the EIR Method, EIR Method         2,874 14,976
Income from Purchased Receivables Under the EIR Method         26,745 15,066
Receipt of Royalty and Commercial Payments, EIR Method         (25,139) (10,309)
Payment of Sales-Based Milestone         3,000  
Balance at End of Period, Royalty and Commercial Payment Receivables, EIR Method         27,213 19,733
Income            
Income from purchased receivables under the EIR method         26,745 15,066
Income from purchased receivables under the cost recovery method         13,744 3,201
Twist            
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method            
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method         15,000  
Acquisition of Royalty and Commercial Payment Receivables, Cost Recovery Method           15,000
Balance at End of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method         15,000 15,000
Dare            
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method            
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method         21,999  
Acquisition of Royalty and Commercial Payment Receivables, Cost Recovery Method           22,000
Receipt of Royalty and Commercial Payments, Cost Recovery Method           (1)
Balance at End of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method           21,999
Dare | XACIATO            
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method            
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method         21,999  
Receipt of Royalty and Commercial Payments, Cost Recovery Method         (6)  
Balance at End of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method         21,993 21,999
LadRx            
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method            
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method         4,850 6,000
Receipt of Royalty and Commercial Payments, Cost Recovery Method           (2,150)
Recognition of Contingent Consideration, Cost Recovery Method           1,000
Balance at End of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method           4,850
LadRx | MIPLYFFA            
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method            
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method         4,850  
Receipt of Royalty and Commercial Payments, Cost Recovery Method         (1,976)  
Reclassification of Royalty and Commercial Payment Receivables from the Cost Recovery to the EIR Method, Cost Recovery Method         (2,874)  
Balance at End of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method           4,850
Royalty and Commercial Payment Receivable Activities Under the EIR Method            
Reclassification of Royalty and Commercial Payment Receivables from the Cost Recovery to the EIR Method, EIR Method         2,874  
Income from Purchased Receivables Under the EIR Method         1,799  
Receipt of Royalty and Commercial Payments, EIR Method         (908)  
Balance at End of Period, Royalty and Commercial Payment Receivables, EIR Method         3,765  
Income            
Income from purchased receivables under the EIR method         1,799  
Palobiofarma            
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method            
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method         10,000 10,000
Balance at End of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method         10,000 10,000
Kuros            
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method            
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method         4,500 4,500
Balance at End of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method         4,500 4,500
Castle Creek Biosciences, Inc            
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method            
Acquisition of Royalty and Commercial Payment Receivables, Cost Recovery Method         4,395  
Balance at End of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method         4,395  
Affitech            
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method            
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method           12,191
Receipt of Royalty and Commercial Payments, Cost Recovery Method           (7,396)
Recognition of Contingent Consideration, Cost Recovery Method           3,000
Reclassification of Royalty and Commercial Payment Receivables from the Cost Recovery to the EIR Method, Cost Recovery Method           (7,795)
Royalty and Commercial Payment Receivable Activities Under the EIR Method            
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, EIR Method         13,105  
Reclassification of Royalty and Commercial Payment Receivables from the Cost Recovery to the EIR Method, EIR Method           7,795
Income from Purchased Receivables Under the EIR Method           14,800
Receipt of Royalty and Commercial Payments, EIR Method           (9,490)
Balance at End of Period, Royalty and Commercial Payment Receivables, EIR Method           13,105
Income            
Income from purchased receivables under the EIR method           14,800
Affitech | VABYSMO            
Royalty and Commercial Payment Receivable Activities Under the EIR Method            
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, EIR Method         13,105  
Income from Purchased Receivables Under the EIR Method         23,957 14,800
Receipt of Royalty and Commercial Payments, EIR Method         (22,507)  
Payment of Sales-Based Milestone         3,000  
Balance at End of Period, Royalty and Commercial Payment Receivables, EIR Method         17,555 13,105
Income            
Income from purchased receivables under the EIR method         23,957 14,800
Aptevo            
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method            
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method           7,976
Receipt of Royalty and Commercial Payments, Cost Recovery Method           (795)
Reclassification of Royalty and Commercial Payment Receivables from the Cost Recovery to the EIR Method, Cost Recovery Method           (7,181)
Royalty and Commercial Payment Receivable Activities Under the EIR Method            
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, EIR Method         6,628  
Reclassification of Royalty and Commercial Payment Receivables from the Cost Recovery to the EIR Method, EIR Method $ 7,200         7,181
Income from Purchased Receivables Under the EIR Method         1,000 266
Receipt of Royalty and Commercial Payments, EIR Method           (819)
Balance at End of Period, Royalty and Commercial Payment Receivables, EIR Method           6,628
Income            
Income from purchased receivables under the EIR method         1,000 266
Aptevo | IXINITY            
Royalty and Commercial Payment Receivable Activities Under the EIR Method            
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, EIR Method         6,628  
Income from Purchased Receivables Under the EIR Method         989 266
Receipt of Royalty and Commercial Payments, EIR Method         (1,724)  
Balance at End of Period, Royalty and Commercial Payment Receivables, EIR Method         5,893 6,628
Income            
Income from purchased receivables under the EIR method         989 266
Viracta            
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method            
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method           8,500
Receipt of Royalty and Commercial Payments, Cost Recovery Method           (8,500)
Viracta | OJEMDA            
Income            
Income from purchased receivables under the cost recovery method         13,716 3,201
Talphera            
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method            
Acquisition of Royalty and Commercial Payment Receivables, Cost Recovery Method           8,000
Receipt of Royalty and Commercial Payments, Cost Recovery Method           (96)
Credit Losses on Purchased Receivables, Cost Recovery Method           (7,904)
Talphera | DSUVIA            
Income            
Income from purchased receivables under the cost recovery method         28  
Royalty receivable           7,900
Agenus            
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method            
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method           14,000
Credit Losses on Purchased Receivables, Cost Recovery Method           (14,000)
Aronora            
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method            
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method           9,000
Credit Losses on Purchased Receivables, Cost Recovery Method           (9,000)
Commercial Payment Purchase Agreement | Affitech            
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method            
Acquisition of Royalty and Commercial Payment Receivables, Cost Recovery Method       $ 14,000    
Royalty and Commercial Payment Receivable Activities Under the EIR Method            
Reclassification of Royalty and Commercial Payment Receivables from the Cost Recovery to the EIR Method, EIR Method   $ 7,800        
Income from Purchased Receivables Under the EIR Method         24,000 14,800
Income            
Income from purchased receivables under the EIR method         $ 24,000 $ 14,800
Commercial Payment Purchase Agreement | Aptevo            
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method            
Acquisition of Royalty and Commercial Payment Receivables, Cost Recovery Method     $ 9,700